Technetium labeling of dextran incorporating cysteamine as a ligand

Henze, 1982, 99mTc dextran: a new blood-pool labeling agent for radionuclide angiocardiography, J. Nucl. Med., 23, 348 Dansereau, 1994, Preparation of dextran 70 injection labeled with technetium 99m for use as a cardiac blood-pool imaging agent, Am. J. Hosp. Pharm., 15, 2797 Henze, 1982, Lymphoscintigraphy with 99mTc labelled dextran, J. Nucl. Med., 23, 923 Ercan, 1985, Evaluation of 99mTc as a lymphoscintigraphic agent in rabbits, Eur. J. Nucl. Med., 11, 80 Wingardh, 1989, Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy, Eur. J. Nucl. Med., 15, 146, 10.1007/BF00254628 Dass, 1993, Development of a dextran kit for labelling with 99mTc and its evaluation for lymphoscintigraphy, Nucl. Med. Biol., 20, 701, 10.1016/0969-8051(93)90041-R Dansereau, 2000, Clinical production of pharmaceutical grade 99mTc dextran 70 for lymphoscintigraphy, Clin. Nucl. Med., 25, 179, 10.1097/00003072-200003000-00003 Bhatnagar, 1995, 99mTc-dextran: a potential inflammation-seeking radiopharmaceutical, Nucl. Med. Commun., 16, 1058, 10.1097/00006231-199512000-00011 Bhatnagar, 1998, Inflammation imaging using 99mTc dextran, Clin. Nucl. Med., 23, 123, 10.1097/00003072-199802000-00021 Bhatnagar, 1995, Scintigraphic diagnosis of protein losing enteropathy using 99mTc dextran, Clin. Nucl. Med., 20, 1070, 10.1097/00003072-199512000-00007 Bhatnagar, 1996, Technetium-99m dextran: a promising new protein-losing enteropathy imaging agent, Eur. J. Nucl. Med., 23, 575, 10.1007/BF00833395 Kapoor, 2002, Detecting protein losing enteropathy by 99mTc dextran scintigraphy: a novel experience, Indian J. Pediatr., 69, 761, 10.1007/BF02723686 Albertini, 1996, Lymphatic mapping and sentinel node biopsy in the patient with breast cancer, JAMA, 11, 1818, 10.1001/jama.1996.03540220042028 Piato, 2003, Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study, Eur. J. Surg. Oncol., 29, 118, 10.1053/ejso.2002.1349 Vigario, 2003, Primary chemotherapy effect in sentinel node detection in breast cancer, Clin. Nucl. Med., 28, 553, 10.1097/00003072-200307000-00004 Edreira, 2001, In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification, Nucl. Med. Commun., 22, 499, 10.1097/00006231-200105000-00006 Neubauer, 2001, Sentinel lymph node mapping in melanoma with technetium-99m dextran, Cancer Biother. Radiopharm., 16, 265, 10.1089/10849780152389447 Xavier, 2001, Sentinel lymph node identification and sampling in women with early breast cancer using 99mTc labelled dextran 500 and patent blue V dye, Nucl. Med. Commun., 22, 1109, 10.1097/00006231-200110000-00009 Holmberg, 1995, Labeling of polypeptides with Technetium-99m using a dextran spacer, Cancer Res., 55, 5710s Marquez, 1996, 99mTc-dextran-antibody conjugates. Labeling procedures, Acta Oncol., 35, 489, 10.3109/02841869609109928 Pearse, 1980, 655 Ellman, 1959, Tissue sulfhydryl groups, Arch. Biochem. Biophys., 82, 70, 10.1016/0003-9861(59)90090-6 Richards, 1967, Technetium-99m-labeled compounds, J. Nucl. Med., 7, 165 Goldstein, 1965, Controlled degradation of polysaccharides by periodate oxidation, reduction, and hydrolysis, Methods Carbohydr. Chem., 5, 361 Koizumi, 2001, Clearance of filtered fluid from the lung during exercise: Role of hyperpnea, Am. J. Respir. Crit. Care Med., 163, 614, 10.1164/ajrccm.163.3.2004205 Mehvar, 1994, Molecular weight dependent tissue accumulation of dextrans: In vivo studies in rats, J. Pharm. Sci., 83, 1495, 10.1002/jps.2600831024